Treatment of venous thrombosis at unusual sites

Current Treatment Options in Cardiovascular Medicine

Volumn 10, Issue 2, 2008, Pages 136-145

  McBane II, Robert D ^a   Wysokinski, Waldemar E ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; NADROPARIN; PLACEBO; WARFARIN;

ABDOMINAL PAIN; BLEEDING; CEREBRAL SINUS THROMBOSIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DECOMPRESSION SURGERY; DISEASE COURSE; DRUG WITHDRAWAL; FIBRINOLYTIC THERAPY; FLANK PAIN; FLAPPING TREMOR; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HEMATURIA; HUMAN; INTESTINE INFARCTION; JAUNDICE; KIDNEY VEIN THROMBOSIS; LAPAROTOMY; LIVER VEIN THROMBOSIS; MESENTERIC VEIN THROMBOSIS; OVARIAN VEIN; OVARIAN VEIN THROMBOSIS; PERITONITIS; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; REVIEW; SPLEEN VEIN THROMBOSIS; SPLENECTOMY; SPLENIC VEIN; THROMBECTOMY; THROMBOSIS; VEIN THROMBOSIS;

EID: 41749088698     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-008-0015-z     Document Type: Review

References (66)

1. Heit JA, O'Fallon WM, Petterson TM, et al.: Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002, 162:1245-1248.
2. Silverstein MD, Heit JA, Mohr DN, et al.: Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998, 158:585-593
3. Heit JA, Silverstein MD, Mohr DN, et al.: Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000, 160:809-815.
4. Geerts WH, Pineo GF, Heit JA, et al.: Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126:338S-400S.
5. Büller HR, Agnelli C, Hull RD, et al.: Antithrombotic therapy for venous thromboembolic disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126:401S-428S.
6. Wysokinski WE, Gosk-Bierska I, Karnicki K, McBane RD: Etiology and natural history of venous thrombosis of atypical location. Phlebologie 2005, 58:275-287.
7. Gosk-Bierska I, Wysokinski WE, Brown RD Jr, et al.: Natural history of cerebral venous sinus thrombosis: incidence of recurrent venous thromboembolism and survival. Neurology 2006, 67:814-819.
8. Lin A, Foroozan R, Danesh-Meyer HV, et al.: Occurrence of cerebral venous sinus thrombosis in patients with presumed idiopathic intracranial hypertension. Ophthalmology 2006, 113:2281-2284.
9. Ferro JM, Canhão P, Bousser MG, et al.: ISCVT Investigators: Cerebral vein and dural sinus thrombosis in elderly patients. Stroke 2005, 36:1927-1932.
10. Einhaupl KM, Villringer A, Meister W, et al.: Heparin treatment in sinus venous thrombosis. Lancet 1991, 338:597-600.
11. de Bruijn S, Stam J: Randomized placebo controlled trial of anticoagulant treatment with low molecular weight heparin for cerebral sinus thrombosis. Stroke 1999, 30:484-488.
12. Rondepierre P, Hamon M, Leys D, et al.: Thromboses veineuses cerebrales; etude de l'evolution. Rev Neurol (Paris) 1995, 151:100-104.
13. Cakmak S, Derex L, Berruyer M, et al.: Cerebral venous thombosis: clinical outcome and systematic screening of prothrombotic factors. Neurology 2003, 60:1175-1178.
14. Ferro JM, Canhão P, Stam J, et al.: ISCVT Investigators: Prognosis of cerebral vein and dural sinus thrombosis. Stroke 2004, 35:664-670.
15. Girot M, Ferro JM, Canhão P, et al.: ISCVT Investigators: Predictors of outcome in patients with cerebral venous thrombosis and intracranial hemorrhage. Stroke 2007, 38:337-342.
16. McCarthy LJ, Titus JL, Daugherty GW: Bilateral renal vein thrombosis and the nephrotic syndrome in adults. Ann Intern Med 1963, 58:837-849.
17. Zucchelli P: Renal vein thrombosis. Nephrol Dial Transplant 1992, 7(Suppl 1):105-108.
18. Velasquez Forero F, Garcia Prugue N, Ruiz Morales N: Idiopathic nephrotic syndrome of the adult with asymptomatic thrombosis of the renal vein. Am J Nephrol 1988, 8:457-462.
19. Wysokinski WE, Gosk-Bierska I, Greene EL, et al.: Clinical characteristics and long-term follow-up of patients with renal vein thrombosis. Am J Kidney Dis 2007, In press.
20. Webster GJM, Burroughs AK, Riordan SM: Portal vein thrombosis - new insights into etiology and management. Aliment Pharmacol Ther 2005, 21:1-9.
21. Ogren M, Bergqvist D, Wahlander K, et al.: Trousseau's syndrome - what is the evidence? A population-based autopsy study. Thromb Haemost 2006, 95:541-545.
22. Okuda K, Ohnishi K, Kimura K, et al.: Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology 1985, 89:279-286.
23. Condat B, Pessione F, Hillaire S, et al.: Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 2001, 120:490-497.
24. Schafer C, Zundler J, Bode JC: Thrombolytic therapy in patients with portal vein thrombosis: case report and review of the literature. Eur J Gastroenterol Hepatol 2000, 12:1141-1145.
25. Henao EA, Bohannon WT, Silva MB Jr: Treatment of portal venous thrombosis with selective superior mesenteric artery infusion of recombinant tissue plasminogen activator. J Vasc Surg 2003, 38:1411-1415.
26. Aytekin C, Boyvat F, Kurt A, et al.: Catheter-directed thrombolysis with transjugular access in portal vein thrombosis secondary to pancreatitis. Eur J Radiol 2001, 39:80-82.
27. Lopera JE, Correa G, Brazzini A, et al.: Percutaneous transhepatic treatment of symptomatic mesenteric venous thrombosis. J Vasc Surg 2002, 36:1058-1061.
28. Liatsos C, Vlachogiannakos J, Patch D, et al.: Successful recanalization of portal vein thrombosis before liver transplantation using transjugular intrahepatic portosystemic shunt. Liver Transpl 2001, 7:453-460.
29. Janssen HL, Wijnhoud A, Haagsma EB, et al.: Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 2001, 49:720-724.
30. Rhee RY, Gloviczki P, Mendonca CT, et al.: Mesenteric venous thrombosis: still a lethal disease in the 1990s. J Vasc Surg 1994, 20:688-697.
31. Grendell JH, Ockner RK: Mesenteric venous thrombosis. Gastroenterology 1982, 82:358-372.
32. Kumar S, Kamath PS: Acute superior mesenteric venous thrombosis: one disease or two? Am J Gastroenterol 2003, 98:1299-1304.
33. Reinus JF, Brandt LJ, Boley SJ: Ischemic diseases of the bowel. Gastroenterol Clin North Am 1990, 19:319-343.
34. Naitove A, Weismann RE: Primary mesenteric venous thrombosis. Ann Surg 1965, 161:516-523.
35. Abdu RA, Zakhour BJ, Dallas DJ: Mesenteric venous thrombosis 1911 to 1984. Surgery 1987, 101:383-388.
36. Mathews JE, White RR: Primary mesenteric venous occlusive disease. Am J Surg 1971, 122:579-583.
37. Morasch MD, Ebaugh JL, Chiou AC, et al.: Mesenteric venous thrombosis: a changing clinical entity. J Vasc Surg 2001, 34:680-684.
38. Rhee RY, Gloviczki P: Mesenteric venous thrombosis. Surg Clin North Am 1997, 77:327-338.
39. Poplausky MR, Kaufman JA, Geller SC, Waltman AC: Mesenteric venous thrombosis treated with urokinase via the superior mesenteric artery. Gastroenterology 1996, 110:1633-1635.
40. Yankes JR, Uglietta JP, Grant J, Braun SD: Percutaneous transhepatic recanalization and thrombolysis of the superior mesenteric vein. AJR Am J Roentgenol 1991, 151:289-290.
41. Rivitz SM, Geller SC, Hahn C, Waltman AC: Treatment of acute mesenteric venous thrombosis with transjugular intramesenteric urokinase infusion. J Vasc Interv Radiol 1995, 6:219-228.
42. Train JS, Ross H, Weiss JD, et al.: Mesenteric venous thrombosis: successful treatment by intraarterial lytic therapy. J Vasc Interv Radiol 1998, 9:461-464.
43. Lopera JE, Correa G, Brazzini A, et al.: Percutaneous transhepatic treatment of symptomatic mesenteric venous thrombosis. J Vasc Surg 2002, 36:1058-1061.
44. Pavel J, Levy MM, Krausz JM: The role of second-look procedure in improving survival time for patients with mesenteric vein thrombosis. Surg Gynecol Obstet 1990, 170:287-291.
45. Inahara T: Acute superior mesenteric venous thrombosis: treatment by thrombectomy. Ann Surg 1971, 174:956-961.
46. Evans GR, Yellin AE, Weaver FA, Stain SC: Sinistral (leftsided) portal hypertension. Am Surg 1990, 56:758-763.
47. Sakorafas GH, Tsiotou AG: Splenic-vein thrombosis complicating chronic pancreatitis. Scand J Gastroenterol 1999, 34:1171-1177.
48. Weber SM, Rikkers LF: Splenic vein thrombosis and gastrointestinal bleeding in chronic pancreatitis. World J Surg 2003, 27:1271-1274.
49. Pietrabissa A, Moretto C, Antonelli G, et al.: Thrombosis in the portal venous system after elective laparoscopic splenectomy. Surg Endosc 2004, 18:1140-1143.
50. Menon KV, Shah V, Kamath PS: The Budd-Chiari syndrome. N Engl J Med 2004, 350:578-585.
51. Valla DC: Prognosis in Budd Chiari syndrome after re-establishing hepatic venous drainage. Gut 2006, 55:761-763.
52. Kamath PS: Budd-Chiari syndrome: radiologic findings. Liver Transpl 2006, 12:S21-S22.
53. Hadengue A, Poliquin M, Vilgrain V, et al.: The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 1994, 106:1042-1047.
54. Ahn SS, Yellin A, Sheng FC, et al.: Selective surgical therapy of the Budd-Chiari syndrome provides superior survivor rates than conservative medical management. J Vasc Surg 1987, 5:28-37.
55. Bilbao JI, Pueyo JC, Longo JM, et al.: Interventional therapeutic techniques in Budd-Chiari syndrome. Cardiovasc Intervent Radiol 1997, 20:112-119.
56. Pisani Ceretti A, Intra M, Prestipino F, et al.: Surgical and radiologic treatment of primary Budd-Chiari syndrome. World J Surg 1998, 22:48-53.
57. Eapen CE, Velissaris D, Heydtmann M, et al.: Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut 2006, 55:878-884.
58. Orloff MJ, Orloff MS, Daily PO: Long-term results of treatment of Budd-Chiari syndrome with portal decompression. Arch Surg 1992, 127:1182-1187.
59. Bismuth H, Sherlock DJ: Portasystemic shunting versus liver transplantation for the Budd-Chiari syndrome. Ann Surg 1991, 214:581-589.
60. Gauthier F, De Dreuzy O, Valayer J, et al.: H-type shunt with an autologous venous graft for treatment of portal hypertension in children. J Pediatr Surg 1989, 24:1041-1043.
61. Horne MK 3rd, Figg WD, Arlen P, et al.: Increased frequency of venous thromboembolism with the combination of docetaxel and thalidomide in patients with metastatic androgen-independent prostate cancer. Pharmacotherapy 2003, 23:315-318.
62. Jacoby WT, Cohan RH, Baker ME, et al.: Ovarian vein thrombosis in oncology patients: CT detection and clinical significance. AJR Am J Roentgenol 1990, 155:291-294.
63. Quane LK, Kidney DD, Cohen AJ: Unusual causes of ovarian vein thrombosis as revealed by CT and sonography. AJR Am J Roentgenol 1998, 171:487-490.
64. Yassa NA, Ryst E: Ovarian vein thrombosis: a common incidental finding in patients who have undergone total abdominal hysterectomy and bilateral salpingo-oophorectomy with retroperitoneal lymph node dissection. AJR Am J Roentgenol 1999, 172:45-47.
65. Witlin AG, Mercer BM, Sibai BM: Septic pelvic thrombophlebitis or refractory postpartum fever of undetermined etiology. J Matern Fetal Med 1996, 5:355-358.
66. Wysokinska EM, Hodge D, McBane RD 2nd: Ovarian vein thrombosis: incidence of recurrent venous thromboembolism and survival. Thromb Haemost 2006, 96:126-131.